Biotechnology News

July 1, 2014

MENLO PARK, Calif.--(BUSINESS WIRE)--Emerald Therapeutics, a scientist-led company re-imagining the way laboratory research is conducted, today announced that it has concluded its latest round of funding, raising the company’s total financing to...

July 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea announces positive top-line 12-month follow-up data from phase 1/2a clinical trial for GEN-003, an immunotherapy in development for herpes simplex virus type 2.

July 1, 2014

BOSTON & SHREVEPORT, La.--(BUSINESS WIRE)--Embera NeuroTherapeutics is receiving a grant from new crowd funding platform Sound Affects Life to support the clinical trial program for its new potential addiction disorder therapy.

July 1, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--New positive efficacy results for single-dose, oral cholera candidate vaccine PXVX0200 announced today by specialty vaccine company PaxVax. Efficacy data adds to successful Phase 3 clinical trial.

July 1, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN), announced final results from a single-arm, multi-institutional, open-label, Phase 2 study showing that patients with newly diagnosed glioblastoma multiforme (GBM) who received Agenus...

July 1, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that Julie H. McHugh,...

July 1, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, joined the broad...

July 1, 2014

DALLAS--(BUSINESS WIRE)--MD Buyline announced today its Q2.2014 User Satisfaction Trending™ data is now available to MD Buyline members. By conducting end-user interviews, MD Buyline’s industry experts evaluate real-world experiences with capital...

July 1, 2014

BASKING RIDGE, New Jersey--(BUSINESS WIRE)--electroCore, the New Jersey based electroceutical company has announced that its successful funding initiative of $40 million, has been oversubscribed by $10 million.

July 1, 2014

LONDON--(BUSINESS WIRE)--Unilever (NYSE: UN, LSE: ULVR) and Celsis International have been awarded the Supply & Demand Chain Executive (SDCE) Top 100 Award 2014, given to companies that successfully execute innovative, transformative supply...

July 1, 2014

ZÜRICH-SCHLIEREN, Switzerland--(BUSINESS WIRE)--Molecular Partners AG announced today results from the Allergan-sponsored, double-masked stage 3 phase 2 study of the DARPin abicipar pegol, for wet age-related macular degeneration (AMD).

July 1, 2014

HARROGATE, England--(BUSINESS WIRE)--Smithers Viscient has this week moved into its new facility in Harrogate, North Yorkshire. The new site is one of the most advanced purpose-built environment laboratories in Europe.

July 1, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration (FDA) for Somatuline® Depot 120mg injection for the...

June 30, 2014

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics Inc, an immunotherapy company developing ValloVaxTM, the first anti-angiogenic cancer vaccine, announced today the appointment of Boris Minev, M.D. to the company’s Scientific Advisory Board (SAB). Dr....

June 30, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Michigan’s biosciences industry saw significant gains according to the Battelle/BIO State Bioscience Jobs, Investments and Innovation 2014 report released last week during the annual BIO International Convention...

June 30, 2014

PITTSBURGH--(BUSINESS WIRE)--Cell biologists have a new imaging and analysis software available to them that offers speed, flexibility and efficiency for large-scale, high-throughput biology, including complex morphological analyses of cells,...

June 30, 2014

CAMBRIDGE, Mass. & SEATTLE--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced the acquisition...

June 30, 2014

BOSTON--(BUSINESS WIRE)--Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for Use of KALYDECO® (ivacaftor) in People 18 and Older with Cystic Fibrosis who have the R117H Mutation

June 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIOGEN IDEC TO REPORT SECOND QUARTER 2014 FINANCIAL RESULTS ON JULY 23, 2014

June 30, 2014

BOSTON--(BUSINESS WIRE)--Boston Strategics Corporation (BSC), an integrated clinical-stage drug research and development (R&D) company, Boston, MA, today announced that it has entered into an exclusive licensing and development agreement with...

June 30, 2014

HOUSTON--(BUSINESS WIRE)--CompanionDx Reference Lab, a high-complexity CLIA certified laboratory specializing in pharmacogenomics, cancer companion diagnostics, targeted next generation sequencing (NGS) and epigenomics testing, is proud to join...

June 30, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE MKT: XXII) today announced that the Company joined the Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes.

June 30, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. (NASDAQ: HRTX), a specialty pharmaceutical company, today announced closing of its underwritten public offering of 4,751,358 shares of common stock at a public offering price of $11....

June 30, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative company specializing in the development of drugs for orphan oncology diseases, and Topotarget A/S (NASDAQ...

June 30, 2014

DENVER--(BUSINESS WIRE)--Colorado BioScience Association (CBSA) is honored to welcome the United States Patent and Trademark Office (USPTO) Rocky Mountain Regional Satellite Office to Denver.

June 30, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE MKT:ATNM), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced...

June 30, 2014

MIAMI--(BUSINESS WIRE)--Brickell Biotech, Inc. (“Brickell“), a clinical-stage pharmaceutical company focused on the development of differentiated, innovative therapeutics to satisfy current unmet human needs in the global dermatology markets,...

June 30, 2014

GREENSBORO, N.C.--(BUSINESS WIRE)--Merz North America, Inc. today announced that it has signed an agreement with Brickell Biotech, Inc. granting Merz an exclusive North American license with certain additional international rights to develop and...

June 30, 2014

MADISON, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes LLC has signed the Radioxenon Emissions Pledge with the Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization.

June 30, 2014

ST. LOUIS--(BUSINESS WIRE)--Washington University in St. Louis has licensed its proprietary genetic sequencing tool to PierianDx, opening the door for other clinical labs to do their own next-generation sequencing.

June 30, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--US Oncology Research and Baylor College of Medicine have recently launched a clinical trial to study a scalp cooling system designed to prevent chemotherapy-induced hair loss (alopecia).

June 30, 2014

SAN ANTONIO--(BUSINESS WIRE)--Healthcare industry veteran to spearhead next generation of interoperability and mobility innovations; AirStrip also names Gabriela Tobal new Director of Culture and Operational Excellence

June 30, 2014

BOSTON & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--In work published in Nature this month, scientists at the Broad Institute and Fluidigm used the C1 Single-Cell Auto Prep System to prepare cells for single-cell sequencing.

June 30, 2014

SUNNYVALE, Calif.--(BUSINESS WIRE)--Icon Bioscience completes patient enrollment in phase 3 study of IBI-10090 for inflammation post cataract surgery. Enrollment completed approximately four months ahead of projected timelines.

June 30, 2014

HEIDELBERG, Germany--(BUSINESS WIRE)--Affimed Files Registration Statement for Proposed Initial Public Offering

June 30, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Announcement under Irish Takeover Rules Relevant Securities in Issue – June 30, 2014

June 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oliver Rosen, M.D., appointed as Chief Medical Officer responsible for leading Deciphera's clinical development strategy and clinical operations

June 30, 2014

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that the Company’s common stock has been added to the...

June 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) announced today that InVivo’s Director of Research Richard Layer, Ph.D., has been invited to speak at the Joint Symposium of the 4th International Neural Regeneration...

June 30, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced updates on three of the Company’s key R&D pipeline programs, including abicipar pegol (Anti-VEGF DARPin®), bimatoprost sustained-release...

June 30, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Announces Data from Investigational Phase 3 Study on EMEND® (aprepitant) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children Undergoing Emetogenic Chemotherapy.

June 30, 2014

SAN DIEGO, Calif.--(BUSINESS WIRE)--Cidara Therapeutics Completes $32 Million Series A Financing

June 30, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the second quarter of 2014 prior to its quarterly earnings call on Thursday, July 31, 2014, at 8:00 a.m. EDT.

June 30, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), today announced its addition to the Russell Microcap® Index.

June 30, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals announced preclinical data demonstrating the promise of DCR-PH1, the Company’s therapeutic candidate for the treatment of primary hyperoxaluria type 1 (PH1).